Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Assay Designs was a life science company that developed and manufactured immunoassay and detection kits for the global research market. Based in Ann Arbor, Michigan, the company offered a broad portfolio of ELISA kits, antibodies, and proteins focused on areas such as inflammation, oxidative stress, and cell signaling. In 2009, Assay Designs was acquired by Enzo Biochem for approximately $12.2 million and was integrated into the Enzo Life Sciences division. The company's products were widely used in academic and pharmaceutical research to quantify biomarkers and study cellular processes. The acquisition allowed Enzo to significantly expand its presence in the high-growth immunoassay market, particularly through Assay Designs' expertise in prostaglandins and cyclic nucleotides.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Assay Designs.